Synergistic Effect of the Combined Action of Targeted and Photodynamic Therapy on HER2-Positive Breast Cancer

被引：0
|
作者：
I. V. Balalaeva
L. V. Krylova
M. A. Karpova
A. A. Shulga
E. V. Konovalova
E. L. Guryev
S. M. Deyev
机构：
[1] Lobachevsky State University of Nizhny Novgorod,
[2] Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry,undefined
[3] Russian Academy of Sciences,undefined
[4] Sechenov First Moscow State Medical University,undefined
来源：
Doklady Biochemistry and Biophysics | 2022年 / 507卷
关键词：
targeted therapy; recombinant anticancer toxin; DARPin-LoPE; photodynamic therapy; photodithazine; breast cancer; HER2 receptor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：330 / 333
页数：3
相关论文
共 50 条
  • [1] Synergistic Effect of the Combined Action of Targeted and Photodynamic Therapy on HER2-Positive Breast Cancer
    Balalaeva, I. V.
    Krylova, L. V.
    Karpova, M. A.
    Shulga, A. A.
    Konovalova, E. V.
    Guryev, E. L.
    Deyev, S. M.
    DOKLADY BIOCHEMISTRY AND BIOPHYSICS, 2022, 507 (01) : 330 - 333
  • [2] Targeted Therapy in HER2-Positive Breast Cancer
    Thill, Marc
    Kraft, Clayton
    Friedrich, Michael
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 (05) : 295 - 302
  • [3] Targeted therapy in HER2-positive breast cancer (Review)
    Li, Shu Guang
    Li, Li
    BIOMEDICAL REPORTS, 2013, 1 (04) : 499 - 505
  • [4] Exploring Targeted Therapy for HER2-Positive Metastatic Breast Cancer
    Terrie, Yvette C.
    US PHARMACIST, 2022, 47 (10) : 34 - 39
  • [5] The Synergistic Effects of Pyrotinib Combined With Adriamycin on HER2-Positive Breast Cancer
    Wang, Chaokun
    Deng, Shuzhen
    Chen, Jing
    Xu, Xiangyun
    Hu, Xiaochen
    Kong, Dejiu
    Liang, Gaofeng
    Yuan, Xiang
    Li, Yuanpei
    Wang, Xinshuai
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [6] Brain Radiotherapy Combined with Targeted Therapy for HER2-Positive Breast Cancer Patients with Brain Metastases
    Tang, Lifeng
    Zhang, Wei
    Chen, Long
    BREAST CANCER-TARGETS AND THERAPY, 2024, 16 : 379 - 392
  • [7] Targeted therapy in HER2-positive metastatic breast cancer: a review of the literature
    Zhu, X.
    Verma, S.
    CURRENT ONCOLOGY, 2015, 22 : S19 - S28
  • [8] Recent advances in nanoscale targeted therapy of HER2-positive breast cancer
    Omidi, Yadollah
    Mobasher, Maha
    Castejon, Ana M.
    Mahmoudi, Morteza
    JOURNAL OF DRUG TARGETING, 2022, 30 (07) : 687 - 708
  • [9] Challenges and prospects in HER2-positive breast cancer-targeted therapy
    Li, Xiyin
    Zhang, Xueying
    Yin, Saige
    Nie, Jianyun
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2025, 207
  • [10] Pertuzumab: A New Targeted Therapy for HER2-Positive Metastatic Breast Cancer
    Malenfant, Stephanie J.
    Eckmann, Karen R.
    Barnett, Chad M.
    PHARMACOTHERAPY, 2014, 34 (01): : 60 - 71
12345